BioVie Inc. (BIVIW) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Sep 29Oct 7Oct 13Oct 16Oct 21Oct 27Oct 30Nov 4

Key dataNov 4, 2026

Open$0.32

From 52W high−34.99%

Volume903.00

Market cap$2.48M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataNov 4, 2026

Open

$0.32

From 52W high

−34.99%

Volume

903.00

Market cap

$2.48M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

P/E (TTM)

—

RSI (14)

51.2

MomentumView details →

1D Return

−13.17%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

—

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

—

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

—

ROA (TTM)

—

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

−13.17%

YTD Return

—

1Y Return

—

RSI (14)

51.2

vs 50D SMA

—

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

—

Quick Ratio

—

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Next earningsDec 2, 2026 →

Latest newsMore news →

No recent news for BIVIW.

Similar companies

Aptevo Therapeutics Inc.APVO VivoSim Labs, Inc.VIVS CASI Pharmaceuticals, Inc.CASI HCW Biologics Inc.HCWB Revelation Biosciences, Inc.REVB BioXcel Therapeutics, Inc.BTAI Find similar companies →

Latest newsMore news →

No recent news for BIVIW.